Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study - Scorecard - MDSpire

Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study

  • By

  • Yushan Chen

  • Lvying Shen

  • Shaoqiang Chen

  • Shunyong Zheng

  • Jianmin Xie

  • Shuishun Zheng

  • May 29, 2026

  • 0 min

Share

Clinical Scorecard: Differentiating Primary Central Nervous System Lymphoma from Tumefactive Demyelinating Lesions in Multiple Sclerosis: A Retrospective Cohort Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsDifferences in clinical observations, neuroimaging data, and pathological features.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              Primary central nervous system lymphoma and tumefactive demyelinating lesions in multiple sclerosis: a retrospective observational cohort study

              • by Yushan Chen, Lvying Shen, Shaoqiang Chen, Shunyong Zheng, Jianmin Xie, Shuishun Zheng

              • May 29, 2026

              Related Content

              Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer

              Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

              Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis